Membership
Tour
Register
Log in
Thomas B. Okarma
Follow
Person
Palo Alto, CA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Device and process for cell capture and recovery
Patent number
6,432,653
Issue date
Aug 13, 2002
Aventis Pharmaceuticals Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Device and process for cell capture and recovery
Patent number
6,143,508
Issue date
Nov 7, 2000
Rhone Poulenc Rorer Pharmaceuticals Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Recombinant adeno-associated virus vectors
Patent number
5,780,280
Issue date
Jul 14, 1998
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Removal of selected factors from whole blood or its components
Patent number
5,730,713
Issue date
Mar 24, 1998
Rhone Poulenc Rorer Pharmaceuticals Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Recombinant adeno-associated virus vector packaging cells and metho...
Patent number
5,691,176
Issue date
Nov 25, 1997
Applied Immune Sciences, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Method for producing recombinant adeno-associated virus vectors
Patent number
5,681,731
Issue date
Oct 28, 1997
Applied Immune Sciences, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Recombinant adeno-associated virus vectors
Patent number
5,589,377
Issue date
Dec 31, 1996
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Removal of selected factors from whole blood or its components
Patent number
5,523,096
Issue date
Jun 4, 1996
Applied Immune Sciences, Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Removal of selected factors from whole blood or its components; and...
Patent number
5,437,861
Issue date
Aug 1, 1995
Applied Immune Sciences, Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Production of recombinant adeno-associated virus vectors
Patent number
5,354,678
Issue date
Oct 11, 1994
Applied Immune Sciences, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
C-terminal conglutinin fragments coupled to solid support
Patent number
5,317,088
Issue date
May 31, 1994
Applied Immune Sciences, Inc.
Young M. Lee
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Stabilization of sterilized surfaces for research and medical use
Patent number
5,283,034
Issue date
Feb 1, 1994
Applied Immune Sciences, Inc.
David A. Okrongly
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Production of recombinant adeno-associated virus vectors
Patent number
5,173,414
Issue date
Dec 22, 1992
Applied Immune Sciences, Inc.
Jane S. Lebkowski
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Device for plasma modification--composition and remodeling
Patent number
5,022,988
Issue date
Jun 11, 1991
Applied ImmuneSciences
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Plasma processing device with anaphylatoxin remover
Patent number
4,963,265
Issue date
Oct 16, 1990
Applied Immunesciences, Inc.
Thomas B. Okarma
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
INTERACTIVE COMPUTING SYSTEM TO GENERATE CUSTOMIZED PREVENTIVE HEAL...
Publication number
20210233663
Publication date
Jul 29, 2021
Rejuvenan Global Health, Inc.
Fereydoun Fred Nazem
G01 - MEASURING TESTING
Information
Patent Application
INTERACTIVE COMPUTING SYSTEM TO GENERATE CUSTOMIZED PREVENTIVE HEAL...
Publication number
20200058404
Publication date
Feb 20, 2020
Rejuvenan Global Health, Inc.
Fereydoun Fred Nazem
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
TREATMENT RECOMMENDATIONS BASED ON BIOMARKER VALUES
Publication number
20180277248
Publication date
Sep 27, 2018
Rejuvenan Global Health, Inc.
Fereydoun Fred Nazem